FDA Announces Approval of Information Collection for Labeling of Nonprescription Human Drug Products

Summary

The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) to collect information related to labeling of nonprescription human drug products marketed without an approved application, as required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act of 1995.